ロード中...
Comparing Paclitaxel–Carboplatin with Paclitaxel–Cisplatin as the Front-Line Chemotherapy for Patients with FIGO IIIC Serous-Type Tubo-Ovarian Cancer
The use of weekly chemotherapy for the treatment of patients with advanced-stage serous-type epithelial Tubo-ovarian cancer (ETOC), and primary peritoneal serous carcinoma (PPSC) is acceptable as the front-line postoperative chemotherapy after primary cytoreductive surgery (PCS). The main component...
保存先:
| 出版年: | Int J Environ Res Public Health |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7177627/ https://ncbi.nlm.nih.gov/pubmed/32224896 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijerph17072213 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|